These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9211073)

  • 1. Hyperlipidaemia and cardiovascular disease.
    Buchalter M
    Curr Opin Lipidol; 1997 Jun; 8(3):U40-1. PubMed ID: 9211073
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of 4S evidence on baseline lipid levels.
    Durrington PN
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of 4S evidence on baseline lipid levels.
    Jacobson TA
    Lancet; 1995 Jul; 346(8968):181-2. PubMed ID: 7603245
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.
    Hutchesson AC; Moran A; Jones AF
    J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of 4S evidence on baseline lipid levels.
    Ravnskov U
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7603244
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlipidaemia and cardiovascular disease.
    Wray R
    Curr Opin Lipidol; 1995 Dec; 6(6):U160-4. PubMed ID: 8750258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Limitations of interventions against hypercholesterolemia].
    Ripoll MA
    Aten Primaria; 1996 Mar; 17(4):305-6. PubMed ID: 8679872
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol synthesis inhibitors in hyperlipidaemia.
    Mol MJ; Stuyt PM; Stalenhoef AF; van 't Laar A
    Lancet; 1988 Mar; 1(8585):597. PubMed ID: 2894538
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
    Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
    Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA
    Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidaemia and cardiovascular disease.
    Le NA
    Curr Opin Lipidol; 2001 Oct; 12(5):587-9. PubMed ID: 11561179
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-lowering therapy in low-risk patients.
    Pearson TA
    JAMA; 1998 May; 279(20):1659-61. PubMed ID: 9613918
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin in the media.
    Watt G; Galbraith W
    N Z Med J; 1989 Dec; 102(881):651-2. PubMed ID: 2608245
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
    Stewart MW; Dyer RG; Alberti KG; Laker MF
    Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
    Lang JE; Wang P; Glueck CJ
    Clin Chim Acta; 1996 Oct; 254(1):65-92. PubMed ID: 8894313
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS
    Clin Ther; 1995; 17(5):901-10. PubMed ID: 8595642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
    Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D
    Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.